1. 200 Evaluating novel peptide therapeutics targeting pathogenic macrophages in systemic sclerosis. (25th April 2018) Authors: Stanway, James; Abdi, Bahja Ahmed; Lopez, Henry; Martin, George; Stratton, Richard J Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Crystal arthropathies. (February 2022) Authors: Tan, Sean Y.W.; Stanway, James; Ellis, Spencer Journal: Medicine Issue: Volume 50:Number 2(2022) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crystal arthropathies. (March 2018) Authors: Stanway, James; Marianayagam, Thiraupathy; Ellis, Spencer Journal: Medicine Issue: Volume 46:Number 3(2018) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0182 SYNTHETIC PEPTIDES TARGETING CD206 INHIBIT PATHOGENIC MACROPHAGES IN SYSTEMIC SCLEROSIS. (June 2019) Authors: Lopez, Henry; Kumar, Kimti; Martin, George; Jaynes, Jesse; Stanway, James; Abdi, Bahja Ahmed; Arumalla, Nikita; Karrar, Sarah; Morris, Sian; Denton, Christopher; Abraham, David; Shiwen, Xu; Stratton, Richard Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P139 Disease modifying treatment: the end of a golden age. (26th April 2021) Authors: Stanway, James; Walker, David Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗